Difference between revisions of "Williamson"
| Line 1: | Line 1: | ||
| − | <span style="line-height:normal">'''<span style="font-size:18.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:18.0pt"><span style="font-family:">No data on the use of hyperbaric oxygen for open tibial fractures</span></span>'''</span> |
| − | <span style="line-height:normal">'''<span style="font-size:14.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:14.0pt"><span style="font-family:">Clinical bottom line:</span></span>'''</span> |
{| class="Table" style="border:undefined" | {| class="Table" style="border:undefined" | ||
|- | |- | ||
| | | | ||
| − | <span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family: | + | <span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:">1. Trial abandoned having recruited only 17 patients in total (target 36 in each group)</span></span></span> |
|} | |} | ||
| Line 13: | Line 13: | ||
---- | ---- | ||
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Citation/s:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">1. Williamson OD, Millar I, Venturoni C. Hyperbaric oxygen and the management of open tibial fractures. Journal of Bone and Joint Surgery – British Volume, Orthopaedic proceedings 2005; 88-B(Suppl II):323.</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Lead author's name and fax:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">I. Millar I.Millar@alfred.org.au</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Three-part Clinical Question:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Does HBOT improve soft tissue healing in adult patients with open tibial fractures?</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Search Terms:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Open tibial fracture; crush injury</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Study:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Non-blinded randomised controlled trial.</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Study Patients:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Adults with lower leg fractures requiring extensive soft tssue and/or vascular repair (Gustillo class 3B and 3C fractures).</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Control group:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">No HBOT, usual management.</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Experimental group:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">As above plus HBOT – dose not reported.</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Evidence:</span></span>'''</span> |
| − | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">None reported.</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Comments:</span></span>'''</span> |
| − | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">1. Reasons for cancellation given were slower than expected recruitment rate and difficulty engaging orthopaedic team owing to pre-existing belief that HBO was efficacious.</span></span></span> |
| − | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">2. No report of any outcome from the 17 enrolled patients.</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Appraised by:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Craig Wilson c.c.wilson@live.co.uk; Friday, 24 November 2017</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Email:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">c.c.wilson@live.co.uk</span></span></span> |
| − | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family: | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Kill or Update By:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">November 2022</span></span></span> |
[[File:Sumhorsa.gif|center|sumhorsa.gif]] | [[File:Sumhorsa.gif|center|sumhorsa.gif]] | ||
Latest revision as of 22:56, 23 August 2022
No data on the use of hyperbaric oxygen for open tibial fractures
Clinical bottom line:
|
1. Trial abandoned having recruited only 17 patients in total (target 36 in each group) |
Citation/s:1. Williamson OD, Millar I, Venturoni C. Hyperbaric oxygen and the management of open tibial fractures. Journal of Bone and Joint Surgery – British Volume, Orthopaedic proceedings 2005; 88-B(Suppl II):323.
Lead author's name and fax:I. Millar I.Millar@alfred.org.au
Three-part Clinical Question:Does HBOT improve soft tissue healing in adult patients with open tibial fractures?
Search Terms:Open tibial fracture; crush injury
The Study:Non-blinded randomised controlled trial.
The Study Patients:Adults with lower leg fractures requiring extensive soft tssue and/or vascular repair (Gustillo class 3B and 3C fractures).
Control group:No HBOT, usual management.
Experimental group:As above plus HBOT – dose not reported.
The Evidence:
None reported.
Comments:
1. Reasons for cancellation given were slower than expected recruitment rate and difficulty engaging orthopaedic team owing to pre-existing belief that HBO was efficacious.
2. No report of any outcome from the 17 enrolled patients.
Appraised by:Craig Wilson c.c.wilson@live.co.uk; Friday, 24 November 2017
Email:c.c.wilson@live.co.uk
Kill or Update By:November 2022
BACK
